A biohacker who allocates a staggering $2 million annually in his quest for immortality has surprised many by revealing ‘erection data’ pertaining to himself and his son.
Bryan Johnson is engaged in an extensive and rigorous experimental medical program aimed at ‘reversing aging’.
His efforts range from adhering to a strict diet to utilizing his son’s blood, all in a bid to maintain a youthful condition.
Johnson has previously claimed that his mission has led him to have the ‘heart of a 37-year-old’ and the ‘lung capacity of an 18-year-old’, though it has not been a simple journey.
As his unusual endeavor gains more attention, partly due to Netflix’s Don’t Die: The Man Who Wants to Live Forever, Johnson has shared a surprising piece of data online.
On Wednesday (January 22), the biohacker took to Twitter to reveal ‘erection data’ for both himself and his son, Talmage.
Admittedly, it is not the type of data one typically expects to come across.
Alongside the data, Johnson remarked: “Nighttime erection data from my 19-year-old son, @talmagejohnson_, and me. His duration is two minutes longer than mine. Raise children to stand tall, be firm, and be upright.”
The data detailed their sleep efficiency, average erection quality, number of erection episodes, and total duration.
Johnson scored a higher average erection quality at 94, compared to his son’s score of 90.
The biohacker also reported better sleep efficiency but had one fewer erection episode than Talmage.
Unsurprisingly, many were curious about how the data was collected, with one individual asking: “Did I ask how you track this? I don’t think I have this activated on my Apple Watch.”
Johnson has indicated that he used a sensor to gather the data.
In response to his father’s tweet, Talmage wrote: “I’m grateful for the way my dad has raised me.”
In addition to his personal mission to preserve youth, Johnson provided his then 70-year-old father with some of his plasma, describing it as ‘the world’s first multigenerational plasma exchange’.
Plasma infusions are typically used to address various health issues, such as liver disease, burns, and blood disorders, rather than for the purpose of reversing aging.
The FDA does not endorse using plasma infusions for age-reversing purposes.
In a 2019 statement, the authority noted: “The FDA has recently become aware of reports of establishments in several states that are offering infusions of plasma from young donors to purportedly treat the effects of a variety of conditions.
“The conditions range from normal aging and memory loss to serious diseases like dementia, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease or post-traumatic stress disorder.
“We have significant public health concerns about the promotion and use of plasma for these purposes. There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions, and there are risks associated